Clinical Trial Update: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity and safety of a group A, C, Y & W-135 meningococcal polysaccharide diphtheria toxoid conjugate vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (A, C, Y, W-135))

Snippet

Sponsor: JN-International Medical Corporation | Conditions: Meningococcal Meningitis, Meningococcal Infections | Phase 2 | Status: COMPLETED | Results posted: 2015-04-23